{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T06:00:33Z","timestamp":1780639233730,"version":"3.54.1"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Patients with congenital adrenal hyperplasia (CAH) often face challenges in achieving their target adult height. The QEPS growth model, previously used for assessing healthy and pathological growth patterns, has not been applied to individuals with CAH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate growth patterns in patients with CAH using the QEPS growth model and to compare their growth characteristics with a healthy reference population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A retrospective longitudinal study analyzing growth data collected from 1986 to 2008.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>The study was conducted in a single tertiary care center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients<\/jats:title>\n                    <jats:p>The study included 25 patients (13 girls) with CAH, subtyped into salt wasting (SW; 12 boys, 8 girls) and simple virilizing (SV; 5 girls). Growth data were compared with a healthy reference cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>All patients were treated with hydrocortisone, and patients with CAH-SW received mineralocorticoids.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>Growth patterns were analyzed using the QEPS model, which includes specific early life growth (E-function), basic childhood growth (Q-function), and specific pubertal growth (P-function). Final adult height was compared with the reference population and parental heights.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>CAH-SW boys and girls were longer at birth, exhibited reduced early-life growth, and had reduced puberty-specific growth (lower Pmax), resulting in shorter adult height (1.7 SDS). CAH-SV girls had earlier pubertal growth onset, also leading to reduced adult height (\u22121.6 SDS). Both groups showed similar basic childhood growth.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with CAH-SW displayed distinct growth patterns, including longer birth length but reduced specific early and pubertal growth, resulting in shorter adult height compared with reference populations and parental heights.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1736405","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:07:39Z","timestamp":1780636059000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Growth patterns in patients with congenital adrenal hyperplasia analyzed by the QEPS growth model"],"prefix":"10.3389","volume":"17","author":[{"given":"Ruta","family":"Navardauskaite","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Lithuanian University of Health Sciences, Medical Academy","place":["Kaunas, Lithuania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimon","family":"Niklasson","sequence":"additional","affiliation":[{"name":"Gothenburg Pediatric-Growth Research Centre (GP-GRC), Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg","place":["Gothenburg, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas F. M.","family":"Nierop","sequence":"additional","affiliation":[{"name":"Gothenburg Pediatric-Growth Research Centre (GP-GRC), Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg","place":["Gothenburg, Sweden"]},{"name":"Muvara bv, Multivariate Analysis of Research Data","place":["Leiderdorp, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldina","family":"Pivodic","sequence":"additional","affiliation":[{"name":"APNC","place":["Gothenburg, Sweden"]},{"name":"Department of Ophthalmology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg","place":["Gothenburg, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasa","family":"Verkauskiene","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Medical Academy, Lithuanian University of Health Sciences.","place":["Kaunas, Lithuania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Holmgren","sequence":"additional","affiliation":[{"name":"Gothenburg Pediatric-Growth Research Centre (GP-GRC), Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg","place":["Gothenburg, Sweden"]},{"name":"Department of Pediatrics, Halland Hospital","place":["Halmstad, Sweden"]},{"name":"Department of Research and Development, Region Halland","place":["Halmstad, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An endocrine society* clinical practice guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2109","article-title":"Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: Deceleration of growth velocity during puberty","volume":"92","author":"Bonfig","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2003.18.8.1539","article-title":"Adrenarche and bone modeling and remodeling at the proximal radius: Weak androgens make stronger cortical bone in healthy children","volume":"18","author":"Remer","year":"2003","journal-title":"J Bone Miner Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1067\/mpd.2001.110527","article-title":"Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: A meta-analysis","volume":"138","author":"Eugster","year":"2001","journal-title":"J Pediatr"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1053\/beem.2002.0198","article-title":"Long-term consequences of childhood-onset congenital adrenal hyperplasia","volume":"16","author":"White","year":"2002","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1203\/PDR.0b013e318177590f","article-title":"Evo-devo of infantile and childhood growth","volume":"64","author":"Hochberg","year":"2008","journal-title":"Pediatr Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00258","article-title":"Testicular adrenal rest tumors: Current insights on prevalence, characteristics, origin, and treatment","volume":"40","author":"Engels","year":"2019","journal-title":"Endocr Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000308","article-title":"Growth and development in children with classic congenital adrenal hyperplasia","volume":"24","author":"Bonfig","year":"2017","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B9","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nrendo.2013.179","article-title":"The role of estrogen and androgen receptors in bone health and disease","volume":"9","author":"Manolagas","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1159\/000049990","article-title":"Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency","volume":"55","author":"Hargitai","year":"2001","journal-title":"Horm Res Paediatr"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2002.01645.x","article-title":"Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: Factors influencing the outcome","volume":"57","author":"Manoli","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41390-021-01790-2","article-title":"Growth pattern evaluation of the Edinburgh and Gothenburg cohorts by QEPS height model","volume":"92","author":"Holmgren","year":"2022","journal-title":"Pediatr Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12887-017-0857-1","article-title":"Insight into human pubertal growth by applying the QEPS growth model","volume":"17","author":"Holmgren","year":"2017","journal-title":"BMC Pediatr"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtbi.2016.06.007","article-title":"Modelling individual longitudinal human growth from fetal to adult life-QEPS I","volume":"406","author":"Nierop","year":"2016","journal-title":"J Theor Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1080\/08035250213216","article-title":"Swedish population-based longitudinal reference values from birth to 18 years of age for height, weight and head circumference","volume":"91","author":"Wikland","year":"2002","journal-title":"Acta Paediatr"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66736-0","article-title":"Congenital adrenal hyperplasia","volume":"365","author":"Merke","year":"2005","journal-title":"Lancet"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1177\/1941874412458678","article-title":"Glucocorticoids","volume":"3","author":"Gensler","year":"2013","journal-title":"Neurohospitalist"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-8-8","article-title":"Continuous growth reference from 24th week of gestation to 24 months by gender","volume":"8","author":"Niklasson","year":"2008","journal-title":"BMC Pediatr"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1173685","article-title":"Regional references vs. international standards for assessing weight and length by gestational age in Lithuanian neonates","volume":"11","author":"Morkuniene","year":"2023","journal-title":"Front Pediatr"},{"key":"B20","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1186\/s12887-021-02954-z","article-title":"Novel type of references for weight aligned for onset of puberty \u2013 using the QEPS growth model","volume":"21","author":"Albertsson-Wikland","year":"2021","journal-title":"BMC Pediatr"},{"key":"B21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000471876","article-title":"The physiology of childhood growth: Hormonal regulation","volume":"88","author":"Benyi","year":"2017","journal-title":"Horm Res Paediatr"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/adc.46.247.350","article-title":"Birthweight in congenital virilizing adrenal hyperplasia","volume":"46","author":"Qazi","year":"1971","journal-title":"Arch Dis Child"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4274\/jcrpe.galenos.2018.2018.0149","article-title":"Birth size in neonates with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"11","author":"D\u00f6rr","year":"2019","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199701000-00005","article-title":"Growth of patients with 21-hydroxylase deficiency: An analysis of the factors influencing adult height","volume":"41","author":"J\u00e4\u00e4skel\u00e4inen","year":"1997","journal-title":"Pediatr Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-005-0075-y","article-title":"Birth length and weight in congenital adrenal hyperplasia according to the different phenotypes","volume":"165","author":"Balsamo","year":"2006","journal-title":"Eur J Pediatr"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2009.173575","article-title":"The role of androgens in fetal growth: Observational study in two genetic models of disordered androgen signalling","volume":"95","author":"Miles","year":"2010","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/2042-6410-2-5","article-title":"Normal sex differences in prenatal growth and abnormal prenatal growth retardation associated with 46,XY disorders of sex development are absent in newborns with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"2","author":"Chalmers","year":"2011","journal-title":"Biol Sex Differ"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1701","article-title":"Absence of increased height velocity in the first year of life in untreated children with simple virilizing congenital adrenal hyperplasia","volume":"91","author":"Claahsen-van der Grinten","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1159\/000322580","article-title":"Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life","volume":"75","author":"Bonfig","year":"2011","journal-title":"Horm Res Paediatr"},{"key":"B30","volume-title":"Williams Obstetrics","author":"Cunningham","year":"2001"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-3460","article-title":"Birth weight in different etiologies of disorders of sex development","volume":"102","author":"Poyrazoglu","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1159\/000023284","article-title":"Androgens and fetal growth","volume":"50","author":"de Zegher","year":"1998","journal-title":"Horm Res Paediatr"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2016-0156","article-title":"Growth curves for congenital adrenal hyperplasia from a national retrospective cohort","volume":"29","author":"Bretones","year":"2016","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2014.11.027","article-title":"The relation of peripubertal and pubertal growth to final adult height in children with classic congenital adrenal hyperplasia","volume":"166","author":"Bomberg","year":"2015","journal-title":"J Pediatr"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab701","article-title":"Characteristics of growth in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency during adrenarche and beyond","volume":"107","author":"Troger","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B36","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1159\/000071876","article-title":"Growth analysis in patients with 21-hydroxylase deficiency influence of glucocorticoid dosage, age at diagnosis, phenotype and genotype on growth and height outcome","volume":"60","author":"Grigorescu-Sido","year":"2003","journal-title":"Horm Res Paediatr"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600710522","article-title":"Oral hydrocortisone pharmacokinetics: A comparison of fluorescence and ultraviolet high-pressure liquid chromatographic assays for hydrocortisone in plasma","volume":"71","author":"Toothaker","year":"1982","journal-title":"J Pharm Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.6.7522","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Alterations in cortisol pharmacokinetics at puberty","volume":"86","author":"Charmandari","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.4158\/EP171751.OR","article-title":"Hydrocortisone therapy and growth trajectory in children with classical congenital adrenal hyperplasia","volume":"23","author":"Bizzarri","year":"2017","journal-title":"Endocrine Pract"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad307","article-title":"Impact of newborn screening on adult height in patients with congenital adrenal hyperplasia (CAH)","volume":"108","author":"Hoyer-Kuhn","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000535403","article-title":"Growth and treatment in congenital adrenal hyperplasia: An observational study from diagnosis to final height","author":"Gidl\u00f6f","year":"2023","journal-title":"Horm Res Paediatr"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae771","article-title":"Anastrozole improves height outcomes in growing children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"110","author":"Al-Rayess","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae824","article-title":"Adult height following prepubertal treatment with antiandrogen, aromatase inhibitor, and reduced hydrocortisone in CAH","volume":"110","author":"Merke","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.937793","article-title":"Adrenal hyperplasias in childhood: an update","volume":"13","author":"Pitsava","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab826","article-title":"Optimizing the timing of highest hydrocortisone dose in children and adolescents with 21-hydroxylase deficiency","volume":"107","author":"Schr\u00f6der","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B46","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1210\/endrev\/bnab016","article-title":"Congenital adrenal hyperplasia\u2014current insights in pathophysiology, diagnostics, and management","volume":"43","author":"Claahsen-van der Grinten","year":"2022","journal-title":"Endocr Rev"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1530\/EC-21-0023","article-title":"Hydrocortisone dosing in children with classic congenital adrenal hyperplasia: results of the German\/Austrian registry","volume":"10","author":"Hoyer-Kuhn","year":"2021","journal-title":"Endocr Connect"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-2699","article-title":"Final adult height in children with congenital adrenal hyperplasia treated with growth hormone","volume":"96","author":"Lin-Su","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B49","doi-asserted-by":"publisher","first-page":"997","DOI":"10.4158\/EP-2019-0610","article-title":"Aromatase inhibitor increases the height of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"26","author":"Xi","year":"2020","journal-title":"Endocrine Pract"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6947-7-40","article-title":"Models predicting the growth response to growth hormone treatment in short children independent of GH status, birth size and gestational age","volume":"7","author":"Dahlgren","year":"2007","journal-title":"BMC Med Inform Decis Mak"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2616","article-title":"Adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis","volume":"95","author":"Muthusamy","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1136\/adc.87.2.139","article-title":"Longitudinal analysis of growth and puberty in 21-hydroxylase deficiency patients","volume":"87","author":"Van der Kamp","year":"2002","journal-title":"Arch Dis Child"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1736405\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:07:40Z","timestamp":1780636060000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1736405\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":52,"alternative-id":["10.3389\/fendo.2026.1736405"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1736405","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"article-number":"1736405"}}